Summary
Lymphokine production by human melanoma tumor-infiltrating lymphocytes (TIL) was studied. Uncultured TIL produced interferon γ (IFNγ), but not interleukin-2 (IL-2) or IL-4, in response to anti-CD3 mAb or IL-2. In bulk cultures, IL-2-activated TIL displaying autologous tumor-specific cytotoxicity (CTL-TIL) produced IFNγ in culture with medium alone, whereas IL-2-activated noncytotoxic TIL did not. Addition of anti-CD3 mAb or autologous tumor cells up-regulated IFNγ production in IL-2-activated TIL from 10 of 12 or 6 of 12 cases respectively. Those from 4 of 12 cases (2 CTL-TIL and 2 noncytotoxic TIL) produced IL-2 in culture with medium alone. At the clonal level, 5 (4 CD4+ and 1 CD8+) of 7 autologous tumor-specific CTL clones derived from TIL and 3 (2 CD4+ and 1 CD8+) of 7 noncytotoxic TIL clones produced IFNγ in culture with medium alone, which was up-regulated by adding anti-CD3 mAb. Two IFNγ-producing CTL clones tested produced IL-2 in 4 ×-concentrated supernatants from a 3.5-h culture with medium alone. Furthermore, 2 IFNγ-producing CTL clones tested expressed mRNA for both IFNγ and IL-2. IL-2 production and its mRNA expression were up- or down-regulated, respectively, by adding anti-CD3 mAb or autologous tumor cells. IL-4 production was not observed in culture either with medium alone or with IL-2 in any of the cells described above. Anti-CD3 mAb was required for IL-4 production in 3 of 12 IL-2-activated TIL, 2 of 6 CTL clones, and none of 5 noncytotoxic TIL clones. In summary, IFNγ production was characteristic of melanoma TIL. Some autologous tumor-specific CTL in TIL are suggested to be productive of IL-2 and IFNγ under unstimulated conditions, both being required for self-activation in an autocrine loop.
Similar content being viewed by others
References
Balch CM, Riley LB, Bae Y-J, Salmeron MA, Platsoucas CD, von Eschenbach AC, Itoh K (1990) Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 126: 200–205
Belldegrun A, Kasid A, Uppenkamp M, Topalian SL, Rosenberg SA (1989) Tumor-infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy. J Immunol 142: 4520–4526
Belldegrun A, Kasid A, Uppenkamp M, Rosenberg SA (1990) Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique anti-tumor specificity isolated from renal cell carcinoma ascitic fluid. Cancer Immunol Immunother 31: 1–10
Ben-Sasson SZ, LeGros G, Conrad DH, Finkelman FD, Paul WE (1990) IL-4 production by T cells from native donors. IL-2 is required for IL-4 production. J Immunol 14: 1127–1136
Cozzolino F, Torcia M, Corossino AM, Giordani R, Selli C, Talini G, Reali E, Novelli A, Pistoia V, Ferrarini M (1987) Characterization of cells from invaded lymph nodes in patients with solidtumors. Lymphokine requirements for tumor-specific lymphoproliferative response. J Exp Med 166: 303–318
Devos R, Cheroutre H, Taya Y, Degrave W, Vanhereverswyn H, Fiers W (1981) Molecular cloning of human immune interferon cDNA and its expression in leukaryotic cells. Nucleic Acids Res 10: 2487–2488
Farrar WL, Johnson HM, Farrar JJ (1981) Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol 126: 1120–1125
Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper cells: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081–2095
Hayakawa K, Salmeron MA, Kornbluth J, Bucana C, Itoh K (1991) The role of IL-4 in proliferation and differentiation of human NK cells. Study of an IL-4-dependent versus an IL-2-dependent NK cell clone. J Immunol 146: 2453–2460
Itoh K, Shiiba K, Shimizu Y, Suzuki R, Kumagai K (1985) Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL-2) in collaboration with interferon-γ (IFNγ). J Immunol 134: 3124–3129
Itoh K, Tilden AB, Kumagai K, Balch CM (1985) Leul 1a+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL2)-induced activated killer (AK) cells. J Immunol 134: 802–807
Itoh K, Tilden AB, Balch CM (1986) Interleukin-2 activation of cytotoxic T lymphocytes infiltrating into human metastatic melanomas. Cancer Res 45: 3173–3178
Itoh K, Platsoucas CD, Balch CM (1988) Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas: activation by interleukin-2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med 168: 1419–1441
Itoh K, Balch CM, Platsoucas CD (1988) Monocyte-independent interleukin 2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin 1 is not required for T cell proliferation. Cell Immunol 115: 36–56
Maraskovsky E, Chen W-F, Shortman K (1989) IL-2 and IFNγ are two necessary lymphokines in the development of cytotoxic T lymphocytes. J Immunol 143: 1210–1214
Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145–173
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RF (1986) Two types of murine helper T cell clones: I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348–2357
Moy PM, Holmes EC, Golub SH (1985) Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. Cancer Res 45: 57–60
Nagarkatti M, Clary SR, Nagarkatti PS (1990) Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties. J Immunol 144: 4898–4905
Paliard X, de Waal-Melefijt R, Yssel H, Blanchard D, Chretien I, Abrams J, deVries JE, Spits H (1988) Simultaneous production of interleukin 2, interleukin 4 and interferon gamma by activated human CD4+ and CD8+ T cell clones. J Immunol 141: 849–855
Patel SS, Duby AD, Thiele DL, Lipsky PE (1988) Phenotypic and functional characterization of human T cell clones. J Immunol 141: 3726–3736
Rotteveel FTM, Kokkelink I, van Lier RAW, Kuenen B, Meager A, Miedema F, Lucas CJ (1988) Clonal analysis of functionally distinct human CD4+ T cell subsets. J Exp Med 168: 1659–1673
Salmon M, Kitas GD, Bacon PL (1989) Production of lymphokine mRNA by CD45R+ and CD45R− helper T cells from human peripheral bloods and human CD4+ cell clones. J Immunol 143: 907–912
Schwartzentruber DJ, Topalian SL, Mancini M, Rosenberg SA (1991) Specific release of granulocyte macrophage colony-stimulatory factor, tumor necrosis factor-α and IFN-γ by tumor-infiltrating lymphocytes after autologous tumor stimulation. J Immunol 146: 3674–3681
Vose BM, Moore M (1977) Suppressor cell activity of lymphocytes infiltrating human lung and breast tumors. Int J Cancer 24: 579–585
Vose BM, Vanky F, Argov S, Klein E (1977) Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes. Eur J Immunol 7: 753–760
Wierenga EA, Snoek M, deGroot C, Chretien I, Bos JD, Jansen HM, Kapsenberg ML (1990) Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 144: 4651–4656
Yagita M, Itoh K, Tsudo M, Owen-Schaub L, Platsoucas CD, Balch CM, Grimm EA (1989) Involvement of both Tac and non-Tac interleukin 2 binding peptides in the interleukin 2-dependent proliferation of human tumor-infiltrating lymphocytes. Cancer Res 49: 1154–1159
Yamada G, Kitamura Y, Sonoda H, Harada H, Taki S, Mulligan RC, Osawa H, Diamanstein T, Yokoyama S, Taniguchi T (1987) Retroviral expression of the human IL2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J 6: 2705–2709
Young HA, Ortaldo JR (1987) One-signal requirement for interferon-γ production by human large granular lymphocytes. J Immunol 139: 724–727
Author information
Authors and Affiliations
Additional information
This work was supported in part by grant CA-47891 from the National Cancer Institute
Rights and permissions
About this article
Cite this article
Salmeron, M.A., Morita, T., Seki, H. et al. Lymphokine production by human melanoma tumor-infiltrating lymphocytes. Cancer Immunol Immunother 35, 211–217 (1992). https://doi.org/10.1007/BF01756190
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01756190